Skip to content

Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy

Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02675634
Enrollment
55
Registered
2016-02-05
Start date
2016-01-31
Completion date
2016-06-30
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colostomy, Ileostomy

Brief summary

This clinical investigation is intended to explore the performance and safety of two newly developed ostomy products with regard to the products fit to body properties.

Interventions

Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

DEVICESubjects own product

The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Have given written informed consent and in DK: signed a letter of authority 2. Are at least 18 years of age and have full legal capacity 3. Have had their ileostomy or colostomy for at least 3 months 4. Are able to use a baseplate cut-max 15 to 40 mm 5. Are able to handle the product themselves 6. Currently using a 1-piece flat product 8. Willing to use an open bag size maxi during the investigation 9. Are able to use a custom cut (custom fit) product 10. Are suitable for participating in the investigation - this means that the subjects must be able to follow all elements of the study procedures.

Exclusion criteria

1. Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis) 2. Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid treatment (e.g. injection, or tablet) are allowed. 3. Are pregnant or breastfeeding\*\* 4. Are participating in other interventional clinical investigations or have previously participated in this investigation 5. Use irrigation during the investigation (flush the intestines with water, this is mostly for people with a colostomy) 6. Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator) 7. Have a loop ostomy (also called double barrel ostomy) 8. Have known hypersensitivity towards any of the products used in the investigation * In DK: women in the child-bearing age will be ask to produce a negative pregnancy test and to sign a form ensuring the use of safe contraception during the investigation.

Design outcomes

Primary

MeasureTime frameDescription
Fit to Body14 +/- 2 daysSubjects will evaluate the fit to body for each product by answering the question how was the baseplates ability to fit the body contours in the area around the stoma? The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.

Countries

Denmark, Netherlands, United Kingdom, United States

Participant flow

Recruitment details

The subjects were recruited through the Coloplast A/S database and from hospital sites

Participants by arm

ArmCount
The Study Population
This consists of all participants who were enrolled in the study
55
Total55

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Test Period 1Adverse Event010100
Test Period 1Device deficiency that did not lead to A001000
Test Period 2Adverse Event000001
Test Period 2Lack of Efficacy100000

Baseline characteristics

CharacteristicThe Study Population
Age, Continuous69 years
STANDARD_DEVIATION 11.2
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
8 / 5211 / 544 / 51
serious
Total, serious adverse events
1 / 520 / 540 / 51

Outcome results

Primary

Fit to Body

Subjects will evaluate the fit to body for each product by answering the question how was the baseplates ability to fit the body contours in the area around the stoma? The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.

Time frame: 14 +/- 2 days

ArmMeasureValue (NUMBER)
Test AFit to Body93 percentage of good or very good
Test BFit to Body88 percentage of good or very good
Own ProductFit to Body57 percentage of good or very good

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026